ADLITE
Adlite Medical Technology (beijing) Co., Ltd.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79279289 |
| Registration Number | 6219045 |
| Mark Drawing Code | 5000: Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form |
Timeline
| 2020-01-13 | Application Filed |
| 2020-02-20 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2020-02-20 | Status: Live/Pending |
| 2020-02-25 | Transaction Date |
| 2020-12-15 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  ADLITE MEDICAL TECHNOLOGY (BEIJING) CO., LTD. |
| Address | Room 364, Floor 3, Building 2, No. 69, Fanyang Rd.,; Fengtai District; CN |
| Legal Entity Type | Corporation |
| Legal Entity State | CN |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-02-20 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2020-02-24 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-02-25 | 3 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2020-02-29 | 4 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2020-03-30 | 5 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-04-01 | 6 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-04-02 | 7 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2020-04-17 | 8 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-04-17 | 9 RFCS P: |
| REFUSAL PROCESSED BY IB | 2020-05-08 | 10 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-08-03 | 11 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2020-08-20 | 12 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-08-21 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-08-21 | 14 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-08-25 | 15 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-09-09 | 16 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2020-09-29 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-09-29 | 18 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-12-15 | 19 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2021-03-15 | 20 FICR P: |
| GENERIC MADRID TRANSACTION CREATED | 2021-03-18 | 21 XXCR P: |
| GENERIC MADRID TRANSACTION SENT TO IB | 2021-03-18 | 22 XXSS O:Outgoing Correspondence |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2021-05-11 | 23 FINO P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ADLITE 87479280 not registered Live/Pending |
BASF SE 2017-06-07 |
 ADLITE 79279289 not registered Live/Pending |
ADLITE MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 2020-01-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 